Magnetic seizure therapy
|This article needs additional citations for verification. (September 2014) (Learn how and when to remove this template message)|
Magnetic seizure therapy (MST) is a proposed form of electrotherapy and electrical brain stimulation. It is currently being investigated for the treatment of treatment-resistant depression (TRD), schizophrenia and obsessive-compulsive disorder. MST is stated to work by inducing seizures via magnetic fields, in contrast to ECT which does so via direct electric shocks. In contrast to (r)TMS, the stimulation rates are higher (e.g. 100 Hz at 2 T) resulting in more energy transfer.
As of 2015 no MST device was commercially available.
- "Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder". U.S. National Institutes of Health. Retrieved 10 May 2013.
- White, PF; Amos, Q; Zhang, Y; Stool, L; Husain, MM; Thornton, L; Downing, M; McClintock, S; Lisanby, SH (July 2006). "Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression.". Anesthesia and analgesia. 103 (1): 76–80, table of contents. PMID 16790630.
- "Minerva". British Medical Journal. 333 (7558): 104. 8 July 2006. PMC .
- Hurley, Dan (December 2015). "The Woman Trying to Rehabilitate Electroshock Therapy". The Atlantic.